Saratov JOURNAL of Medical and Scientific Research

Comparison of uveal melanoma molecular classification systems

Year: 2018, volume 14 Issue: №4 Pages: 898-890
Heading: Ophtalmology Article type: Original article
Authors: Yarovoy А.А., Yarovaya V.A., Chudakova L.V., Chochaeva A.M., Loginov R.A., Kleyankina S.S., Zaretsky A.R.
Organization: Evrogen Laboratory LLC, The S. Fyodorov Eye Microsurgery Federal State Institution

Purpose: to compare cytogenetic and mutational classifications of uveal melanoma (UM) in comprehensive analysis. Material and Methods. UM tissue from 154 eyes treated by enucleation or eye-sparing treatment was analyzed. Analysis included FISH for monosomy 3 and 8q gain, PCR for GNAQ, GNA11, EIF1AX and SF3B1 mutations and immunohistochemistry for BAP1. The group of 66 patients was used to compare cytogenetic and mutational classifications of uveal melanoma. Results. Discrepancy between cytogenetic and mutational classifications was revealed in 79% of cases. Unusual combination of EIF1 AX mutation with monosomy 3 or BAP1 inactivation was seen. Conclusion. Prognostic significance of the discrepancy between the two UM classifications is currently unknown. Further research is needed.

1 Damato BE, Heimann H, Kalirai H, et al. Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival. JAMA Ophthalmol 2014; 132 (5): 605-13
2 Nathan P, Cohen V, Coupland S, et al. Uveal melanoma UK national guidelines. European Journal of Cancer 2016; 51 (16): 2404-12
3 Yang J, Manson DK, Marr BP, et al. Treatment of uveal melanoma: where are we now. Ther Adv Med Oncol 2018; 10: 1758834018757175
4 Yarovaya VA, Kleyankina SS, Golubeva OV, et al. Prognostic molecular "portrait" of uveal melanoma. Sovremennye tekhnologii v ophthalmologii 2017; (4): 215-8
5 Amaro A, Gangemi R, Piaggio F, et al. The biology of uveal melanoma. Cancer Metastasis Rev 2017; 36 (1): 109-40
6 Sisley K, Rennie IG, Parsons MA, et al. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis Genes, Chromosomes & Cancer 1997; 19(1): 22-8
7 Van den Bosch T, van Beek JG, Vaarwater J, et al. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis. Investigative Ophthalmology & Visual Science2012; 53 (6): 2668-74
8 Martin M, Masshofer L, Temming P, et al. Exome sequencing identifies recurrent somaticmutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3 Nature Genetics 2013; 45 (8): 933-6
9 Yavuzyigitoglu S, KoopmansAE, Verdijk RM, et al. Uveal melanomas with SF3B1 mutations: a distinct subclassassociated with late-onset metastases. Ophthalmology 2016; 123 (5): 1118-28
10 Onken MD, Worley LA, Ehlers JP, et al. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Research 2004; 64 (20): 7205-9
11 Onken MD, Worley LA, Char DH, et al. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology 2012; 119 (8): 1596-603
12 Yarovaya VA, Yarovoy AA, Kleyankina SS, et al. Uveal melanoma molecular testing: findings. Sovremennye tekhnologii v ophthalmologii 2018; (4): 297-9
13 Yarovaya VA, Kleyankina SS, Yarovoy AA, et al. Prognostic biopsy of uveal melanoma: technique, pathology and genetic testing. Sovremennye tekhnologii v ophthalmologii 2017; (1): 375-7
14 Klufas MA, Richter Е, Itty S, et al. Comparison of Gene Expression Profiling and Chromosome 3 Analysis by Fluorescent in situ Hybridization and Multiplex Ligation Probe Amplification in Fine-Needle Aspiration Biopsy Specimens of Uveal Melanoma. Ocul Oncol Pathol 2017; 4 (1): 16-20
15 Bellerive C, Grossniklaus HE, Singh AD. Prognostication for Uveal Melanoma: Are Two Tests Better than One? Ocul Oncol Pathol 2017; 3 (4): 301-3.

2018_4-2_898-900.pdf256.23 KB

No votes yet